Natriuretic Peptide Improves Death Risk Prediction of Maggic Heart Failure Risk Model

被引：0
|
作者：
Yoo, ByungSu
Khanam, Sayma Sabrina
Choi, Eunhee
Son, JungWoo
Park, SangWook
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Heart failure; Mortality; Natriuretic peptide;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19654
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Metabolic Signature Improves Heart Failure Risk Prediction In Older Adults
    Liu, Guning
    Nguyen, Quynh
    Agarwal, Sunil K.
    Aguilar, David
    Boerwinkle, Eric
    Chang, Patricia
    Claggett, Brian
    Loehr, Laura R.
    Matsushita, Kunihiro
    Rodriguez, Carlos
    Rossi, Joseph
    Russell, Stuart D.
    Stacey, Brandon
    Heiss, Gerardo M.
    Shah, Amil
    Yu, Bing
    CIRCULATION, 2021, 143
  • [22] Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: Results from a pilot study in elderly chronic heart failure patients
    Cabassi, Aderville
    de Champlain, Jacques
    Maggiore, Umberto
    Parenti, Elisabetta
    Coghi, Pietro
    Vicini, Vanni
    Tedeschi, Stefano
    Cremaschi, Elena
    Binno, Simone
    Rocco, Rossana
    Bonali, Salvatore
    Bianconcini, Michele
    Guerra, Clelia
    Folesani, Giuseppina
    Montanari, Alberto
    Regolisti, Giuseppe
    Fiaccadori, Enrico
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 3334 - 3339
  • [23] Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure
    Isnard, R
    Pousset, F
    Chafirovskaïa, O
    Carayon, A
    Hulot, JS
    Thomas, D
    Komajda, M
    AMERICAN HEART JOURNAL, 2003, 146 (04) : 729 - +
  • [24] Plasma B-type Natriuretic Peptide Levels and the Risk of Death in Clinically-referred Patients With and Without Heart Failure
    York, Michelle K.
    Reynolds, Cassandra F.
    Farber-Eger, Eric
    Wells, Quinn S.
    Bachmann, Katherine N.
    Xu, Meng
    Harrell, Frank
    Gupta, Deepak K.
    Wang, Thomas J.
    CIRCULATION, 2016, 134
  • [25] BRAIN NATURETIC PEPTIDE AND THE RISK OF HEART FAILURE AND DEATH IN MADIT-CRT
    Brenyo, Andrew
    Barsheshet, Alon
    Moss, Arthur
    Rao, Mohan
    McNitt, Scott
    Zareba, Wojciech
    Goldenberg, Ilan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E944 - E944
  • [26] From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure
    AbouEzzeddine, Omar F.
    French, Benjamin
    Mirzoyev, Sultan A.
    Jaffe, Allan S.
    Levy, Wayne C.
    Fang, James C.
    Sweitzer, Nancy K.
    Cappola, Thomas P.
    Redfield, Margaret M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (06): : 714 - 721
  • [27] NATRIURETIC PEPTIDES VERSUS A CLINICAL HISTORY OF HEART FAILURE FOR RISK PREDICTION IN PATIENTS WITH DIABETES
    Bergmark, Brian
    Morrow, David
    Bhatt, Deepak L.
    Raz, Itamar
    Steg, Philippe
    Mosenzon, Ofri
    Gurmu, Yared
    Braunwald, Eugene
    Scirica, Benjamin M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 681 - 681
  • [28] Sudden cardiac death and pump failure death prediction in chronic heart failure by combining ECG and clinical markers in an integrated risk model
    Ramirez, Julia
    Orini, Michele
    Minchole, Ana
    Monasterio, Violeta
    Cygankiewicz, Iwona
    de Luna, Antonio Bayeas
    Martinez, Juan Pablo
    Laguna, Pablo
    Pueyo, Esther
    PLOS ONE, 2017, 12 (10):
  • [29] The combination of brain natriuretic peptide, enhanced ventilatory response to exercise and echocardiographyc indexes improves risk stratification in patients with chronic heart failure
    Scardovi, A. B.
    Perna, S.
    Coletta, C.
    De Maria, R.
    Aspromonte, N.
    D'errigo, P.
    Ricci, R.
    Ceci, V.
    EUROPEAN HEART JOURNAL, 2006, 27 : 15 - 15
  • [30] Combination of B-type Natriuretic Peptide and MIBG wash out rate improves risk stratification in patients with advanced heart failure
    Despas, F.
    Cagnac, R.
    Guerrierro, E.
    Senard, J. M.
    Galinier, M.
    Pathak, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 26 - 26
12345